NIH scientists developed faster COVID-19 test
On Aug. 16, 2021, scientists at the National Institutes of Health (NIH) announced they had developed a new…
Pfizer and BioNTech announced submission of initial data to FDA to support booster dose of COVID-19 vaccine
On Aug. 16, 2021, Pfizer and BioNTech announced that they had submitted Phase 1 data to the U.S….
Cote d’Ivoire declared first Ebola outbreak in more than 25 years
On Aug. 14, 2021, the Ministry of Health of Cote d’Ivoire confirmed the country’s first case of Ebola…
COVID-19 | FDA | Life Science History | NIH
FDA declined to issue Rigel Pharma EUA for fostamatinib for teatment of COVID-19 in hospitalized adults
On Aug. 13, 2021, Rigel Pharma announced that the U.S. Food and Drug Administration (FDA) had informed the…
U.S. FDA approved TICOVACï¾™, Pfizerï¾’s tick-borne encephalitis vaccine
On Aug. 13, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved TICOVACï¾™ (tick-borne…
Monoclonal antibody prevented malaria in small NIH trial
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
NIH launched study of third COVID-19 vaccine dose in kidney transplant recipients
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
Cardinal Health partnered with Abbott and Quidel to offer rapid OTC COVID-19 tests
On Aug. 10, 2021, Cardinal Health announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19…
FDA approved new treatment for Pompe Disease
On Aug. 6, 2021, the U.S. Food and Drug Administration approved Genzyme’s Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion…
CDC reported vaccination offers higher protection than previous COVID-19 infection
On Aug. 6, 2021, the Centers for Disease Control and Prevention (CDC) annouced in MMWR that a study…
NIH-funded study discovered gene involved in male infertility
On Aug. 5, 2021, an international team of researchers announced that a mutation in a single gene appeared…
Lenzilumab treatment may provide enhanced likelihood of survival without ventilation in hospitalized black and African-American COVID-19 patients
On Aug. 4, 2021, Humanigen announced analysis of results from its Phase 3 LIVE-AIR study of lenzilumab in…
Bio-Techne’s RNAscopeï¾™ aids in tissue diagnosis of COVID-19 in cases with no previous SARS-CoV-2 testing
On Aug. 4, 2021, Bio-Techne announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC)…
Vanda closed enrollment in ODYSSEY study comparing tradipitant and placebo In COVID-19 pneumonia patients
On Aug. 3, 2021, Vanda Pharmaceuticals announced that enrollment had closed in the ODYSSEY study comparing tradipitant and…
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…
FDA cleared Vaxart’s IND application for S-only oral tablet COVID-19 vaccine candidate
On Aug. 2, 2021, Vaxart announced that the U.S. Food and Drug Administration had cleared Vaxart’s Investigational New…
MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa
On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…
NIH advanced ACTIV-5/BET-B trial evaluating lenzilumab from phase 2 study to phase 2/3 trail for treatment of COVID-19
On Jul. 30, 2021, Humanigen announced that the NIH had advanced the ACTIV-5/BET-B study to a Phase 2/3…
FDA expanded authorized use of REGEN-COVï¾™ (casirivimab and imdevimab)
On Jul. 30, 2021, Regeneron announced that the FDA had updated the Emergency Use Authorization (EUA) for the…
National Science Foundation partnerships expand National AI Research Institutes to 40 states
On Jul. 29, 2021, the National Science Foundation announced the establishment of 11 new NSF National Artificial Intelligence…
Oxford vaccine reached one billion doses released
On Jul. 29, 2021, the University of Oxfordï¾’s and AstraZeneca announced that one billion doses of the ChAdOx1…
Researchers identified a cellular defect common to familial and sporadic forms of ALS
On Jul. 28, 2021, the National Institutes of Health announced that by studying lab-grown neurons derived from skin…
COVID-19 vaccine delivered into nose of research animals reduced nasal virus shedding
On Jul. 27, 2021, the National Institutes of Health announced that the COVID-19 vaccine AZD1222, when delivered into…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Life Science History | Therapeutics | Vaccine
The COVID-19 Vaccine
Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…
Phase I trial began of new vaccine against the Plague
On Jul. 26, 2021, researchers at the University of Oxford launched a Phase 1 trial to test a…
Trevena announced first patient enrolled in NIH-funded ACTIV-4 host tissue trial of TRV027 for COVID-19
On Jul. 26, 2021, Trevena announced that the first COVID-19 patient had been enrolled in the NIH-funded ACTIV-4…
COVAX and World Bank accelerated COVID-19 vaccine access for developing countries
On Jul. 26, 2021, COVAX and the World Bank accelerated COVID-19 vaccine supply for developing countries through a…
American Medical Association announced support of COVID-19 vaccine mandates for health care workers
On Jul. 26, 2021, the American Medical Association (AMA) call for all health care and long-term care employers…
American Nurses Association supported mandated COVID-19 vaccinations for nurses and all health care professionals
On Jul. 26, 2021, the American Nurses Association (ANA), representing the interests of the nationï¾’s 4.2 million registered…
Relief announced that U.S. collaboration had reporteded successful commercial formulation for aviptadil
On Jul. 23, 2021, RELIEF THERAPEUTICS announced that the parent company of its collaboration partner, NRx Pharmaceuticals, reported…